Skip to main content

Table 3 Regional wall LV function in studies 1 and 2

From: Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus

Study 1

Pre-DSE

Peak stress

Recovery

Control

HHC

P

Control

HHC

P

Control

HHC

P

Vs (cm/s)

4.7 ± 1.7

4.8 ± 1.8

0.10

8.5 ± 3.3

8.6 ± 3.9

0.22

4.1 ± 1.6

4.6 ± 3.1

0.02

Strain (%)

−17.1 ± 6.9

−16.9 ± 7.7

0.46

−15.8 ± 7.0

−15.9 ± 6.9

0.62

−14.3 ± 6.9

−15.3 ± 7.0

0.06

Strain rate (s−1)

−1.1 ± 0.4

−1.1 ± 0.5

0.66

−1.8 ± 0.9

−1.8 ± 0.8

0.89

−1.0 ± 0.5

−1.0 ± 0.5

0.75

Study 2

Control

GLP-1

P

Control

GLP-1

P

Control

GLP-1

P

Vs (cm/s)

4.58 ± 1.62

4.56 ± 1.58

0.82

9.33 ± 3.25

9.78 ± 3.21

0.008

4.46 ± 1.48

5.01 ± 1.67

<0.0001

Strain (%)

−15.18 ± 5.94

−15.06 ± 5.05

0.77

−15.51 ± 5.39

−18.09 ± 6.58

<0.0001

−14.29 ± 5.35

−16.62 ± 5.71

<0.0001

Strain rate (s−1)

−1.04 ± 0.36

−1.06 ± 0.35

0.50

−2.02 ± 0.71

−2.30 ± 0.75

<0.0001

−0.96 ± 0.31

−1.18 ± 0.36

<0.0001